This lack of antigen expression—with the notable exception of disialoganglioside (GD)-2—in NB has been responsible for the well-recognized ability of MYCN-A tumors to escape a cytotoxic T cell (CTL) and interferon-mediated immune response [62]. The gene discussed is MYCN; the disease is neuroblastoma.